# Cladribine Tablets After Treatment With Natalizumab (CLADRINA)

> **NCT04178005** · PHASE4 · ACTIVE_NOT_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 40 (estimated)

## Conditions studied

- Multiple Sclerosis

## Interventions

- **DRUG:** Cladribine

## Key facts

- **NCT ID:** NCT04178005
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2020-02-19
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-12
- **Target enrollment:** 40 (ESTIMATED)
- **Last updated:** 2025-12-08

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04178005

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04178005, "Cladribine Tablets After Treatment With Natalizumab (CLADRINA)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT04178005. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*